Hydroxyproline excretion in urine does not differ between healthy individuals and liver cirrhosis patients. This finding indicates that hydroxyproline levels are not a reliable biomarker for diagnosing or monitoring liver cirrhosis progression.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Context:
Purpose:
Summary:
Impact: